Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies

Urology

Volumn 48, Issue 3, 1996, Pages 406-415

  Roehrborn, Claus G ^a   Siegel, Richard L ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN;

ABDOMINAL PAIN; ARTICLE; BACKACHE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; HEADACHE; HUMAN; HYPOTENSION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SOMNOLENCE; SYMPTOMATOLOGY; URINE FLOW RATE; VERTIGO;

EID: 0030248565     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00208-7     Document Type: Article

References (14)

1. Boyarsky S, Jones G, Paulson DF, and Prout GR Jr: A new look at bladder neck obstruction by the Food and Drug Administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genito-Urinary Surg 68: 29-31, 1977.
2. Bolognese JA, Kozloff RC, Kunitz SC, Grino PB, Patrick DL, and Stoner E: Validation of a symptoms questionnaire for benign prostatic hyperplasia. Prostate 21: 247-254, 1992.
3. Madsen PO, and Iversen P: A point system for selecting operative candidates, in Hinman F (Ed) : Benign Prostatic Hypertrophy. New York, Springer-Verlag, 1983, pp 763-765.
4. Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, and Hanley D: Symptom status and quality of life following prostatectomy. JAMA 259: 3018-3022, 1988.
5. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, and Cockett AT: The American Urological Association symptom index for benign prostatic hyperplasia: the Measurement Committee of the American Urological Association. J Urol 148: 1549-1557, 1992.
6. McConnell JD, Barry MJ, Bruskewitz RC, Bueschen AJ, Denton SE, Holtgrewe HL, Lange JL, McClennan BL, Mebust WK, and Reilly NJ: Benign Prostatic Hyperplasia: Diagnosis and Treatment. Quick Reference Guide for Clinicians. (AHCPR pub. no. 94-0583). Rockville, Maryland, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994.
7. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, and Mebust WK: Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indices: Measurement Committee of the American Urological Association. J Urol 148: 1558-1563, 1992.
8. Mebust WK, Bosch R, Donovan J, Okada K, O'Leary MA, Villers A, Ackermann R, Batista JE, Boyle P, Denis L, et al: Symptom evaluation, quality of life and sexuality, in Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, and Murphy G (Eds): Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Jersey, Channel Islands, Scientific Communication International, 1993, pp 129-138.
9. Boyle P, MacFarlane G, McGrath C, Pagano F, Green J, Griffith K, Van der Sluis W, Altwein J, Vela-Navarette R, and Martin-Moreno J, et al: Cultural and linguistic validation of the international prostate symptom score in seven European countries, (abstract 682) J Urol 153: 399A, 1995.
10. Fawzy A, Sullivan J, Cook M, and Gonzalez F: A multicenter sixteen-week double blind placebo-controlled doseresponse study using doxazosin tablets for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension. J Urol 149: 323A, 1993.
11. Fawzy A, Braun K, Lewis GP, Gaffney M, and Ice K: Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study. J Urol 154: 105-109, 1995.
12. Gillenwater JY, and Mobley DL: A sixteen week, double-blind, placebo controlled, dose-titration study using doxazosin tablets for the treatment of benign prostatic hyperplasia (BPH) in normotensive males. J Urol 149: 324A, 1993.
13. Gillenwater JY, Conn RL, Chrysant SG, Roy J, Gaffney M, Ice K, and Dias N: Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study. J Urol 154: 110-115, 1995.
14. Fulton B, Wagstaff AJ, and Sorkin EM: Doxazosin: an update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 49: 295-320, 1995.